Sugar Maple Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History
Sugar Maple Asset Management, LLC
- $118 Million
- Q1 2025
A detailed history of Sugar Maple Asset Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 10,300 shares of HALO stock, worth $605,537. This represents 0.56% of its overall portfolio holdings.
Number of Shares
10,300
Previous 7,800
32.05%
Holding current value
$605,537
Previous $372,000
76.61%
% of portfolio
0.56%
Previous 0.3%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
555Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$781 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$422 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$245 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$203 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.19B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...